EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Open Access · CC BY-NC 4.0

Patient‐Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two‐Year Results From an International Phase III Study

Nicolino Ruperto iD, Daniel J Lovell iD, Alberto Berman, Francisco Ávila-Zapata, Gerd Horneff, Maria Alessio iD, Mara L Becker, Alexandre Belot, Ruben Burgos-Vargas, Maria L Gamir, Claudia Goldenstein-Schainberg, Iloite M Scheibel und 8 weitere

Arthritis Care & Research · 2023

DOI: 10.1002/acr.24989 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Arthritis Care & Research, 2023. Verfasst von Nicolino Ruperto und 19 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Istituto G. Gaslini Clinica Pediatrica e Reumatologia, UOSID Centro Trial, PRINTO, Genova, Italy. Hauptthemen laut MEDLINE: Arthritis, Juvenile, Antirheumatic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To describe longitudinal changes in patient‐reported outcomes (PROs) in children with polyarticular‐course juvenile idiopathic arthritis (pJIA) treated with subcutaneous abatacept.

Methods

Secondary analysis of a single‐arm, open‐label 24‐month study of patients ages 6–17 years and 2–5 years. PROs included Childhood Health Assessment Questionnaire‐Disability Index (CHAQ‐DI), parent global assessment of child well‐being (PaGA), pain assessment, and Activity Limitation Questionnaire (ALQ). Clinical outcomes included 50% or greater improvement in JIA American College of Rheumatology (ACR) criteria, clinically inactive disease, and Juvenile Arthritis Disease Activity Score.

Results

For the 6‐ to 17‐year‐old (n = 173) and 2‐ to 5‐year‐old (n = 46) cohorts, respectively, median (Q1, Q3) changes from baseline in CHAQ‐DI at months 4 and 24 were −0.3 (−0.8, 0.0) and −0.5 (−1.0, −0.1), and −0.4 (−0.8, 0.0) and −0.5 (−1.0–−0.1). Median pain scores were below cutoff threshold for clinically relevant pain (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, JuvenileAntirheumatic AgentsChildHumansAdolescentChild, PreschoolAbataceptTreatment OutcomePatient Reported Outcome MeasuresPain

Substanzen

AbataceptAntirheumatic Agents

Autor:innen und Institutionen

  • IRCCS Istituto G. Gaslini Clinica Pediatrica e Reumatologia, UOSID Centro Trial, PRINTO, Genova, Italy.
  • Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
  • Universidad Nacional de Tucuman, San Miguel de Tucumán, Argentina.
  • Hospital Star Medica Merida, Yuc, Mexico.
  • Asklepios Clinical Sankt Augustin, Sankt Augustin, Germany, and University of Cologne, Cologne, Germany.
  • Universita di Napoli, Napoli, Italy.

ORCID-Profile: Nicolino Ruperto, Daniel J Lovell, Maria Alessio, Hermine I Brunner

Zitieren

APA

Ruperto, N., Lovell, D. J., Berman, A., Ávila-Zapata, F., Horneff, G., Alessio, M., Becker, M. L., Belot, A., Burgos-Vargas, R., Gamir, M. L., Goldenstein-Schainberg, C., Scheibel, I. M., Terreri, M. T., Zemel, L., Zhuo, J., Askelson, M., Wong, R., Martini, A., Brunner, H. I., & Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation (2023). Patient‐Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two‐Year Results From an International Phase III Study. Arthritis Care & Research. https://doi.org/10.1002/acr.24989

Vancouver

Ruperto N, Lovell DJ, Berman A, Ávila-Zapata F, Horneff G, Alessio M, et al. Patient‐Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two‐Year Results From an International Phase III Study. Arthritis Care & Research. 2023. doi:10.1002/acr.24989

BibTeX
@article{Ruperto2023,
  author = {Ruperto, Nicolino and Lovell, Daniel J and Berman, Alberto and Ávila-Zapata, Francisco and Horneff, Gerd and Alessio, Maria and Becker, Mara L and Belot, Alexandre and Burgos-Vargas, Ruben and Gamir, Maria L and Goldenstein-Schainberg, Claudia and Scheibel, Iloite M and Terreri, Maria T and Zemel, Lawrence and Zhuo, Joe and Askelson, Margarita and Wong, Robert and Martini, Alberto and Brunner, Hermine I and Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation, Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation},
  title = {Patient‐Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two‐Year Results From an International Phase III Study},
  journal = {Arthritis Care & Research},
  year = {2023},
  doi = {10.1002/acr.24989}
}
Kostenlos starten →